Security der nächsten Generation WKN: A3CSAU ISIN: CA74767K1030 Forum: Aktien User: Bonsaifan

Danke für den Beitrag. Finde zwar komisch, dass er nur auf die Wartezeit eingeht, und nicht, ob die 4$ Grenze gültig ist oder nicht. Insgesamt hört es sich doch gut an und er bestätigt meine gestrige Vermutung, dass FB im Vorfeld Beratungsgespräche geführt hat.

"Several German forums are discussing the possibility that the uplisting will fail due to the $4 rule. I thought the NYSE America also lists lower. Can someone clarify the actual situation? Thanks in advance for your answers." Antwort von James , krown ceo : Alright T — happy to clarify this. Yes, the 30-day hold is standard following a Form 40-F filing and has nothing to do with stock performance or listing risk. It’s simply an administrative review window used by the exchange to finalize approvals before trading officially begins. Short-term price movement during this phase is also very common. Liquidity thins out, some holders take profits, and others sit on the sidelines waiting for confirmation. None of that factors into NYSE or AMEX listing decisions. What actually matters is compliance and engagement. Quantum eMotion has already filed its 40-F and has had productive, constructive meetings and calls with the executive teams involved. That’s exactly what a healthy uplisting process looks like. If there were any issues, the process would pause, additional disclosures would be requested, or timelines would formally change. None of that is happening here. So yes—this window is normal, the volatility is expected, and there’s nothing in what’s occurring that jeopardizes a listing on the NYSE or AMEX. This stage is about finalization, not qualification.

"Several German forums are discussing the possibility that the uplisting will fail due to the $4 rule. I thought the NYSE America also lists lower. Can someone clarify the actual situation? Thanks in advance for your answers." Antwort von James , krown ceo : Alright T — happy to clarify this. Yes, the 30-day hold is standard following a Form 40-F filing and has nothing to do with stock performance or listing risk. It’s simply an administrative review window used by the exchange to finalize approvals before trading officially begins. Short-term price movement during this phase is also very common. Liquidity thins out, some holders take profits, and others sit on the sidelines waiting for confirmation. None of that factors into NYSE or AMEX listing decisions. What actually matters is compliance and engagement. Quantum eMotion has already filed its 40-F and has had productive, constructive meetings and calls with the executive teams involved. That’s exactly what a healthy uplisting process looks like. If there were any issues, the process would pause, additional disclosures would be requested, or timelines would formally change. None of that is happening here. So yes—this window is normal, the volatility is expected, and there’s nothing in what’s occurring that jeopardizes a listing on the NYSE or AMEX. This stage is about finalization, not qualification.

Also Maddin wenn wir schon bis Los Angeles mit Greybox Aufmerksamkeit bekommen... Denke ich das Rollout läuft gut an und Frau Khan macht einen guten Job... Für dich zählen nur Fakten ist ok für mich... Ich schaue was in der Zukunft passieren könnte...

Schöne Spekulation zum Start des Wochenendes...

Hab ich da was falsch verstanden? Da wird nichts von der NYSE kommen so lange wir nicht mindestens 3 Monate lang konstant über 4 US-DOLLAR liegen.

Hab ich da was falsch verstanden? Da wird nichts von der NYSE kommen so lange wir nicht mindestens 3 Monate lang konstant über 4 US-DOLLAR liegen.

Die Rolle von Dr. Afshan M. Khan: Als Director of Quality & Risk Management bei ScionHealth ist sie für Patientensicherheit und regulatorische Standards verantwortlich. In dieser Funktion sind quantensichere Lösungen zur Sicherung sensibler Gesundheitsdaten ein zentrales Thema für das Risikomanagement. Quelle mein Quantenrechner... Schönes Wochenende...